Get the composition of our in-house portfolios

All portfolios and performance
Portfolio Ref: EQ3515LS2W
Performance in the last:
Follow this Portfolio
1D 1.2 %
1W 0.6 %
2W 0.6 %
1M 1.6 %
3M 14.5 %
6M -67.3 %
9M -64.3 %
1Y -67.2 %
Alpha
-80.0%
Beta
0.47
sharpe-R
-0.85
Benchmark
SP500 (SPDR S&P 500 ETF Trust)
sharpe-R Benchmark
2.16
The portfolio metrics Alpha, Beta and Sharpe Ratio are computed using a risk free rate of 0%.
Other Information
Calculation Frequency Daily
Latest Valuation Time 2024-09-18 07:49:47
Launch Date 2023-01-01 00:00:00
First Valuation Date 2021-01-01 00:00:00
Max. DrawDown -75.48%
Max. DrawDown Benchmark -8.41%

This Long-Short strategy aims to find promising assets to invest in for a maximum holding period of 2 Weeks in the Equity asset class. This portfolio focuses only on companies in the Health Care sector. The maximum number of assets that can be allocated in this strategy is 15.

The assets selection in this portfolio is based on: Macro-Pattern Mix St..
Please note that all model portfolios assume that the entry price for each trade is the previous close price.

For Long-Short model portfolios, the short-selling costs (asset borrowing costs) are not taken into account. This assumption is likely unrealistic, and it is important to understand the short-selling process before employing this type of strategy.

Portfolio Performance against the market Benchmark

Try Our Peformance Checker Tool

Risk Level
3
Difficulty Level
4

Do you want to invest in this strategy ?

Follow the portfolio and you will get notified for every change in the composition of the portfolio

Current Portfolio Composition

Asset Asset Class Action Weight PnL
PDSB PDS Biotechnology Corporation Equity Buy 10.1% 3.65%
NVAX Novavax, Inc. Equity Buy 9.92% 1.81%
ESPR Esperion Therapeutics, Inc. Equity Buy 13.26% 2.3%
RGNX REGENXBIO Inc. Equity Buy 12.14% 1.89%
AGEN Agenus Inc. Equity Buy 12.05% 5.06%
LLY Eli Lilly and Company Equity Buy 11.11% -3.08%
SRNE Sorrento Therapeutics, Inc. Equity Buy 12.14% -8.33%
IRTC iRhythm Technologies, Inc. Equity Buy 12.53% -6.66%
TDOC Teladoc Health, Inc. Equity Buy 15.12% 12.61%
MRSN Mersana Therapeutics, Inc. Equity Buy 12.98% -3.32%
CARA Cara Therapeutics, Inc. Equity Sell -5.67% 4.98%
SIGA SIGA Technologies, Inc. Equity Sell -6.16% -4.93%
BGNE BeiGene, Ltd. Equity Sell -5.93% -0.63%
CHRS Coherus BioSciences, Inc. Equity Sell -5.66% 0.95%
KIDS OrthoPediatrics Corp. Equity Sell -6.59% 0%
The percentage of cash held in the portfolio is: 8.65%
** The description of each asset is available Here

The latest 5 Compositions change

2024-09-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.1% 3.65%
NVAX Novavax, Inc. Buy 9.92% 1.81%
ESPR Esperion Therapeutics, Inc. Buy 13.26% 2.3%
RGNX REGENXBIO Inc. Buy 12.14% 1.89%
AGEN Agenus Inc. Buy 12.05% 5.06%
LLY Eli Lilly and Company Buy 11.11% -3.08%
SRNE Sorrento Therapeutics, Inc. Buy 12.14% -8.33%
IRTC iRhythm Technologies, Inc. Buy 12.53% -6.66%
TDOC Teladoc Health, Inc. Buy 15.12% 12.61%
MRSN Mersana Therapeutics, Inc. Buy 12.98% -3.32%
CARA Cara Therapeutics, Inc. Sell -5.67% 4.98%
SIGA SIGA Technologies, Inc. Sell -6.16% -4.93%
BGNE BeiGene, Ltd. Sell -5.93% -0.63%
CHRS Coherus BioSciences, Inc. Sell -5.66% 0.95%
KIDS OrthoPediatrics Corp. Sell -6.59% 0%
The percentage of cash held in the portfolio is: 8.65%
New Assets Added
  • KIDS
Assets Removed
None
Assets Rebalanced
Asset Action Weight
ESPR Buy 1.41%
RGNX Buy 1.46%
SRNE Buy 1.63%
2024-09-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.16% 1.66%
NVAX Novavax, Inc. Buy 10.38% 3.94%
RGNX REGENXBIO Inc. Buy 10.78% 0.24%
ESPR Esperion Therapeutics, Inc. Buy 10.88% 1.15%
SRNE Sorrento Therapeutics, Inc. Buy 10.39% -11.67%
AGEN Agenus Inc. Buy 12.06% 2.53%
LLY Eli Lilly and Company Buy 11.62% -1.23%
IRTC iRhythm Technologies, Inc. Buy 13.25% -3.8%
TDOC Teladoc Health, Inc. Buy 13.89% 0.87%
MRSN Mersana Therapeutics, Inc. Buy 12.86% -6.64%
CARA Cara Therapeutics, Inc. Sell -5.83% 4.63%
SIGA SIGA Technologies, Inc. Sell -6.41% -6.39%
BGNE BeiGene, Ltd. Sell -6.04% -0.09%
CHRS Coherus BioSciences, Inc. Sell -5.86% 0%
The percentage of cash held in the portfolio is: 7.88%
New Assets Added
  • CHRS
Assets Removed
None
Assets Rebalanced
None
2024-09-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 9.82% -0.33%
NVAX Novavax, Inc. Buy 10.56% 7.17%
RGNX REGENXBIO Inc. Buy 10.72% 1.02%
ESPR Esperion Therapeutics, Inc. Buy 11.65% 9.77%
SRNE Sorrento Therapeutics, Inc. Buy 8.7% -25%
AGEN Agenus Inc. Buy 12.25% 5.56%
LLY Eli Lilly and Company Buy 11.46% -1.21%
IRTC iRhythm Technologies, Inc. Buy 13.59% 0%
TDOC Teladoc Health, Inc. Buy 13.59% 0%
MRSN Mersana Therapeutics, Inc. Buy 13.59% 0%
CARA Cara Therapeutics, Inc. Sell -5.65% 6.41%
SIGA SIGA Technologies, Inc. Sell -6.25% -5.19%
BGNE BeiGene, Ltd. Sell -6.03% -1.13%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • IRTC
  • TDOC
  • MRSN
Assets Removed
None
Assets Rebalanced
None
2024-09-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.02% 1.33%
NVAX Novavax, Inc. Buy 9.28% -6.14%
RGNX REGENXBIO Inc. Buy 10.2% -4.17%
ESPR Esperion Therapeutics, Inc. Buy 10.71% 0.57%
SRNE Sorrento Therapeutics, Inc. Buy 11.64% 0%
AGEN Agenus Inc. Buy 11.64% 0%
LLY Eli Lilly and Company Buy 11.64% 0%
CARA Cara Therapeutics, Inc. Sell -5.82% 3.91%
SIGA SIGA Technologies, Inc. Sell -6.25% -4.79%
BGNE BeiGene, Ltd. Sell -5.98% 0%
The percentage of cash held in the portfolio is: 42.9%
New Assets Added
  • SRNE
  • AGEN
  • LLY
  • BGNE
Assets Removed
None
Assets Rebalanced
None
2024-09-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 10.12% 2.99%
NVAX Novavax, Inc. Buy 9.51% -3.23%
RGNX REGENXBIO Inc. Buy 10.58% 0%
ESPR Esperion Therapeutics, Inc. Buy 10.58% 0%
CARA Cara Therapeutics, Inc. Sell -6.3% -4.63%
SIGA SIGA Technologies, Inc. Sell -5.93% 0%
The percentage of cash held in the portfolio is: 71.42%
New Assets Added
  • RGNX
  • ESPR
  • SIGA
Assets Removed
None
Assets Rebalanced
None
2024-09-11 00:00:00 : Portfolio change date
Asset Action Weight PnL
PDSB PDS Biotechnology Corporation Buy 9.8% 0%
NVAX Novavax, Inc. Buy 9.8% 0%
CARA Cara Therapeutics, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 86.4%
New Assets Added
  • PDSB
  • NVAX
  • CARA
Assets Removed
None
Assets Rebalanced
None
2024-08-30 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
KIDS Sell All 12.95%
Assets Rebalanced
None
2024-08-27 00:00:00 : Portfolio change date
Asset Action Weight PnL
KIDS OrthoPediatrics Corp. Buy 12.4% 15.23%
The percentage of cash held in the portfolio is: 87.6%
New Assets Added
None
Assets Removed
Asset Action Perf %
OFIX Buy All -7.98%
Assets Rebalanced
None
2024-08-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
KIDS OrthoPediatrics Corp. Buy 11.76% 8.86%
OFIX Orthofix Medical Inc. Sell -6.14% -3.87%
The percentage of cash held in the portfolio is: 94.38%
New Assets Added
None
Assets Removed
Asset Action Perf %
ICUI Sell All 4.94%
VCYT Sell All 3.64%
INGN Sell All 4.71%
CPRX Sell All 13.33%
Assets Rebalanced
None
2024-08-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
ICUI ICU Medical, Inc. Buy 11.08% 3.93%
VCYT Veracyte, Inc. Buy 10.49% 5.54%
INGN Inogen, Inc. Buy 10.21% 6.86%
CPRX Catalyst Pharmaceuticals, Inc. Buy 11.37% 11.86%
KIDS OrthoPediatrics Corp. Buy 12.21% 13.75%
OFIX Orthofix Medical Inc. Sell -6.08% -3.62%
The percentage of cash held in the portfolio is: 50.73%
New Assets Added
None
Assets Removed
Asset Action Perf %
MD Sell All 12.88%
EXEL Sell All -0.72%
Assets Rebalanced
None
2024-08-21 00:00:00 : Portfolio change date
Asset Action Weight PnL
MD Pediatrix Medical Group, Inc. Buy 11.9% 11.63%
EXEL Exelixis, Inc. Buy 11.17% -0.15%
ICUI ICU Medical, Inc. Buy 11.05% 2.58%
VCYT Veracyte, Inc. Buy 10.62% 5.74%
INGN Inogen, Inc. Buy 10.39% 7.54%
CPRX Catalyst Pharmaceuticals, Inc. Buy 11.61% 13.06%
KIDS OrthoPediatrics Corp. Buy 11.18% 3.08%
OFIX Orthofix Medical Inc. Sell -6.05% -2%
The percentage of cash held in the portfolio is: 28.13%
New Assets Added
None
Assets Removed
Asset Action Perf %
THC Sell All 6.2%
GKOS Sell All 6.82%
AXSM Sell All 3.09%
Assets Rebalanced
None
2024-08-20 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 11.16% 6.86%
GKOS Glaukos Corporation Buy 11.16% 8.37%
AXSM Axsome Therapeutics, Inc. Buy 11.16% 5.57%
MD Pediatrix Medical Group, Inc. Buy 11.86% 11.94%
EXEL Exelixis, Inc. Buy 11.16% 0.26%
ICUI ICU Medical, Inc. Buy 11.03% 2.98%
VCYT Veracyte, Inc. Buy 10.78% 7.91%
INGN Inogen, Inc. Buy 10.45% 8.83%
CPRX Catalyst Pharmaceuticals, Inc. Buy 11.16% 9.23%
KIDS OrthoPediatrics Corp. Buy 11.16% 3.44%
OFIX Orthofix Medical Inc. Sell -6.04% -2.43%
The percentage of cash held in the portfolio is: -5.01%
New Assets Added
None
Assets Removed
Asset Action Perf %
CVS Buy All -1.71%
Assets Rebalanced
Asset Action Weight
INGN Sell -1.54%
EXEL Sell -1.16%
THC Sell -1.29%
KIDS Sell -1.32%
GKOS Sell -1.41%
CPRX Sell -2.25%
AXSM Sell -2.49%
2024-08-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.6% 7.18%
GKOS Glaukos Corporation Buy 12.78% 9.17%
AXSM Axsome Therapeutics, Inc. Buy 13.15% 0.76%
EXEL Exelixis, Inc. Buy 12.32% -0.64%
MD Pediatrix Medical Group, Inc. Buy 11.57% 8.1%
CPRX Catalyst Pharmaceuticals, Inc. Buy 13.46% 8.58%
INGN Inogen, Inc. Buy 12.26% 10.11%
ICUI ICU Medical, Inc. Buy 11.32% 4.68%
VCYT Veracyte, Inc. Buy 11.05% 9.61%
KIDS OrthoPediatrics Corp. Buy 12.05% -1.01%
CVS CVS Health Corporation Sell -7.53% -0.93%
OFIX Orthofix Medical Inc. Sell -6% -0.62%
The percentage of cash held in the portfolio is: -9.04%
New Assets Added
None
Assets Removed
Asset Action Perf %
VREX Buy All 2.93%
CDXS Buy All 11.82%
Assets Rebalanced
Asset Action Weight
ICUI Sell -1.65%
VCYT Sell -2.53%
INGN Sell -1.39%
AXSM Buy 1.69%
2024-08-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
THC Tenet Healthcare Corporation Buy 12.55% 6.15%
GKOS Glaukos Corporation Buy 12.62% 7.22%
AXSM Axsome Therapeutics, Inc. Buy 11.45% 0.11%
EXEL Exelixis, Inc. Buy 12.37% -0.79%
MD Pediatrix Medical Group, Inc. Buy 11.51% 6.96%
VCYT Veracyte, Inc. Buy 13.58% 8.98%
INGN Inogen, Inc. Buy 13.47% 8.05%
CPRX Catalyst Pharmaceuticals, Inc. Buy 13.56% 8.8%
ICUI ICU Medical, Inc. Buy 13.02% 4.47%
KIDS OrthoPediatrics Corp. Buy 12.24% 0%
VREX Varex Imaging Corporation Sell -5.81% 3.08%
CDXS Codexis, Inc. Sell -5.1% 14.85%
CVS CVS Health Corporation Sell -7.47% 0.43%
OFIX Orthofix Medical Inc. Sell -6.1% -1.75%
The percentage of cash held in the portfolio is: -1.9%
New Assets Added
  • KIDS
Assets Removed
Asset Action Perf %
RCM Sell All -1.13%
BLUE Buy All 34.26%
Assets Rebalanced
None
2024-08-13 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 12.86% -1.27%
THC Tenet Healthcare Corporation Buy 12.8% 3.64%
GKOS Glaukos Corporation Buy 12.8% 4.07%
AXSM Axsome Therapeutics, Inc. Buy 11.87% -0.7%
EXEL Exelixis, Inc. Buy 13.23% 1.55%
MD Pediatrix Medical Group, Inc. Buy 11.82% 5.19%
VCYT Veracyte, Inc. Buy 13% -0.17%
INGN Inogen, Inc. Buy 13.15% 1.03%
CPRX Catalyst Pharmaceuticals, Inc. Buy 13.73% 5.46%
ICUI ICU Medical, Inc. Buy 12.74% -2.17%
BLUE bluebird bio, Inc. Sell -5.63% 9.26%
VREX Varex Imaging Corporation Sell -5.2% 16.95%
CDXS Codexis, Inc. Sell -5.35% 14.55%
CVS CVS Health Corporation Sell -7.57% 3.46%
OFIX Orthofix Medical Inc. Sell -6.26% 0%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • OFIX
Assets Removed
Asset Action Perf %
RVNC Buy All -95.85%
Assets Rebalanced
Asset Action Weight
MD Sell -1.88%
AXSM Sell -2.45%
THC Sell -2.14%
GKOS Sell -2.2%
RCM Buy 2.86%
2024-08-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.6% -1.13%
GKOS Glaukos Corporation Buy 14.26% 3.2%
THC Tenet Healthcare Corporation Buy 14.19% 2.7%
AXSM Axsome Therapeutics, Inc. Buy 13.74% -0.61%
MD Pediatrix Medical Group, Inc. Buy 12.75% 2.08%
EXEL Exelixis, Inc. Buy 12.79% 2.45%
ICUI ICU Medical, Inc. Buy 12.49% 0%
INGN Inogen, Inc. Buy 12.49% 0%
VCYT Veracyte, Inc. Buy 12.49% 0%
CPRX Catalyst Pharmaceuticals, Inc. Buy 12.49% 0%
RVNC Revance Therapeutics, Inc. Sell -5.21% 12.46%
BLUE bluebird bio, Inc. Sell -5.56% 6.48%
VREX Varex Imaging Corporation Sell -5.27% 12.25%
CDXS Codexis, Inc. Sell -5.73% 4.55%
CVS CVS Health Corporation Sell -7.52% -0.07%
The percentage of cash held in the portfolio is: 2%
New Assets Added
  • ICUI
  • INGN
  • VCYT
  • CPRX
Assets Removed
None
Assets Rebalanced
None
2024-08-08 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.67% -1.2%
GKOS Glaukos Corporation Buy 13.83% -0.69%
THC Tenet Healthcare Corporation Buy 13.86% -0.46%
AXSM Axsome Therapeutics, Inc. Buy 13.65% -1.95%
MD Pediatrix Medical Group, Inc. Buy 12.58% 0%
EXEL Exelixis, Inc. Buy 12.58% 0%
RVNC Revance Therapeutics, Inc. Sell -5.01% 16.32%
BLUE bluebird bio, Inc. Sell -5.21% 12.96%
VREX Varex Imaging Corporation Sell -5.33% 11.79%
CDXS Codexis, Inc. Sell -5.53% 8.48%
CVS CVS Health Corporation Sell -7.4% 2.32%
The percentage of cash held in the portfolio is: 52.32%
New Assets Added
  • MD
  • EXEL
Assets Removed
Asset Action Perf %
TNDM Sell All -11.11%
CERS Sell All -11.06%
Assets Rebalanced
None
2024-08-07 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.57% -1.27%
TNDM Tandem Diabetes Care, Inc. Buy 11.46% 4.13%
CERS Cerus Corporation Buy 10.26% -6.81%
GKOS Glaukos Corporation Buy 13.79% 0%
THC Tenet Healthcare Corporation Buy 13.79% 0%
AXSM Axsome Therapeutics, Inc. Buy 13.79% 0%
RVNC Revance Therapeutics, Inc. Sell -5.42% 8.61%
BLUE bluebird bio, Inc. Sell -5.6% 5.56%
VREX Varex Imaging Corporation Sell -5.37% 10.25%
CDXS Codexis, Inc. Sell -5.84% 2.42%
CVS CVS Health Corporation Sell -7.57% -0.92%
The percentage of cash held in the portfolio is: 57.15%
New Assets Added
  • GKOS
  • THC
  • AXSM
Assets Removed
None
Assets Rebalanced
None
2024-08-06 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.62% -1.27%
TNDM Tandem Diabetes Care, Inc. Buy 10.84% -2.11%
CERS Cerus Corporation Buy 10.46% -5.53%
RVNC Revance Therapeutics, Inc. Sell -5.42% 9.2%
BLUE bluebird bio, Inc. Sell -5.47% 8.33%
VREX Varex Imaging Corporation Sell -5.71% 5.08%
CDXS Codexis, Inc. Sell -5.86% 2.73%
CVS CVS Health Corporation Sell -7.54% 0%
The percentage of cash held in the portfolio is: 99.08%
New Assets Added
  • CVS
Assets Removed
None
Assets Rebalanced
None
2024-08-05 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.74% -0.57%
TNDM Tandem Diabetes Care, Inc. Buy 11.12% 0%
CERS Cerus Corporation Buy 11.12% 0%
RVNC Revance Therapeutics, Inc. Sell -5.69% 5.04%
BLUE bluebird bio, Inc. Sell -6.16% -2.78%
VREX Varex Imaging Corporation Sell -6.05% 0%
CDXS Codexis, Inc. Sell -6.05% 0%
The percentage of cash held in the portfolio is: 91.97%
New Assets Added
  • TNDM
  • CERS
  • VREX
  • CDXS
Assets Removed
None
Assets Rebalanced
None
2024-08-02 00:00:00 : Portfolio change date
Asset Action Weight PnL
RCM R1 RCM Inc. Buy 9.8% 0%
RVNC Revance Therapeutics, Inc. Sell -6% 0%
BLUE bluebird bio, Inc. Sell -6% 0%
The percentage of cash held in the portfolio is: 102.2%
New Assets Added
  • RCM
  • RVNC
  • BLUE
Assets Removed
None
Assets Rebalanced
None
2024-07-24 00:00:00 : Portfolio change date
No Asset in the portfolio
The percentage of cash held in the portfolio is: 100%
New Assets Added
None
Assets Removed
Asset Action Perf %
SNDX Sell All 3.15%
SAGE Sell All 14.04%
ATXS Sell All 14.43%
TVTX Sell All 3.06%
BLUE Sell All 24%
Assets Rebalanced
None
2024-07-23 00:00:00 : Portfolio change date
Asset Action Weight PnL
SNDX Syndax Pharmaceuticals, Inc. Buy 10.84% 3.63%
SAGE Sage Therapeutics, Inc. Buy 11.67% 11.6%
ATXS Astria Therapeutics, Inc. Buy 10.96% 15.51%
TVTX Travere Therapeutics, Inc. Buy 9% 1.69%
BLUE bluebird bio, Inc. Buy 9.86% 14%
The percentage of cash held in the portfolio is: 47.68%
New Assets Added
None
Assets Removed
Asset Action Perf %
CERS Sell All 18.37%
AVXL Sell All 31.04%
Assets Rebalanced
None
2024-07-22 00:00:00 : Portfolio change date
Asset Action Weight PnL
CERS Cerus Corporation Buy 10.15% 12.24%
AVXL Anavex Life Sciences Corp. Buy 10.08% 21.51%
SNDX Syndax Pharmaceuticals, Inc. Buy 11.03% 2.26%
SAGE Sage Therapeutics, Inc. Buy 11.56% 7.15%
ATXS Astria Therapeutics, Inc. Buy 10.76% 9.91%
TVTX Travere Therapeutics, Inc. Buy 9.43% 3.27%
BLUE bluebird bio, Inc. Buy 9.37% 5%
The percentage of cash held in the portfolio is: 27.63%
New Assets Added
None
Assets Removed
Asset Action Perf %
MCRB Sell All 25.9%
MODV Buy All 7.31%
Assets Rebalanced
None
2024-07-19 00:00:00 : Portfolio change date
Asset Action Weight PnL
CERS Cerus Corporation Buy 10.05% 12.76%
AVXL Anavex Life Sciences Corp. Buy 10.35% 26.61%
MCRB Seres Therapeutics, Inc. Buy 9.14% 29.5%
SNDX Syndax Pharmaceuticals, Inc. Buy 10.95% 2.88%
SAGE Sage Therapeutics, Inc. Buy 11.29% 6.1%
ATXS Astria Therapeutics, Inc. Buy 10.47% 8.44%
TVTX Travere Therapeutics, Inc. Buy 9.31% 3.37%
BLUE bluebird bio, Inc. Buy 10.12% 15%
MODV ModivCare Inc. Sell -4.5% 6.4%
The percentage of cash held in the portfolio is: 22.82%
New Assets Added
None
Assets Removed
Asset Action Perf %
NKTR Sell All 4.65%
Assets Rebalanced
None
2024-07-18 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 10.26% 12.4%
CERS Cerus Corporation Buy 10.26% 20.41%
AVXL Anavex Life Sciences Corp. Buy 10.26% 31.26%
MCRB Seres Therapeutics, Inc. Buy 10.26% 52.11%
SNDX Syndax Pharmaceuticals, Inc. Buy 10.67% 4.96%
SAGE Sage Therapeutics, Inc. Buy 10.77% 5.93%
ATXS Astria Therapeutics, Inc. Buy 10.26% 11.19%
TVTX Travere Therapeutics, Inc. Buy 9.34% 8.43%
BLUE bluebird bio, Inc. Buy 10.26% 22%
MODV ModivCare Inc. Sell -4.6% -0.04%
The percentage of cash held in the portfolio is: 12.26%
New Assets Added
None
Assets Removed
None
Assets Rebalanced
Asset Action Weight
TVTX Sell -1.69%
ATXS Sell -1.05%
NKTR Sell -1.7%
BLUE Sell -2.15%
CERS Sell -3.11%
AVXL Sell -4.31%
MCRB Sell -6.62%
2024-07-17 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 12.14% 13.95%
AVXL Anavex Life Sciences Corp. Buy 14.37% 29.27%
CERS Cerus Corporation Buy 13.55% 21.94%
MCRB Seres Therapeutics, Inc. Buy 14.51% 30.52%
TVTX Travere Therapeutics, Inc. Buy 10.96% 7.69%
ATXS Astria Therapeutics, Inc. Buy 11.83% 16.19%
SNDX Syndax Pharmaceuticals, Inc. Buy 11.19% 9.92%
SAGE Sage Therapeutics, Inc. Buy 10.79% 6.02%
BLUE bluebird bio, Inc. Buy 13.74% 35%
MODV ModivCare Inc. Sell -4.7% -2.16%
The percentage of cash held in the portfolio is: -8.37%
New Assets Added
None
Assets Removed
Asset Action Perf %
DNLI Buy All -10.12%
AGEN Buy All -21.82%
Assets Rebalanced
None
2024-07-16 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 11.85% 8.53%
AVXL Anavex Life Sciences Corp. Buy 14.73% 29.27%
CERS Cerus Corporation Buy 13.08% 14.8%
MCRB Seres Therapeutics, Inc. Buy 13.93% 22.3%
TVTX Travere Therapeutics, Inc. Buy 10.79% 3.37%
ATXS Astria Therapeutics, Inc. Buy 12.12% 16.09%
SNDX Syndax Pharmaceuticals, Inc. Buy 11.27% 8.02%
SAGE Sage Therapeutics, Inc. Buy 10.74% 2.88%
BLUE bluebird bio, Inc. Buy 13.78% 32%
DNLI Denali Therapeutics Inc. Sell -5.77% -7.31%
AGEN Agenus Inc. Sell -5.52% -7.36%
MODV ModivCare Inc. Sell -4.58% 2.87%
The percentage of cash held in the portfolio is: 3.6%
New Assets Added
None
Assets Removed
Asset Action Perf %
NUTX Buy All -37.1%
Assets Rebalanced
None
2024-07-12 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 12.4% 5.43%
AVXL Anavex Life Sciences Corp. Buy 13.45% 9.53%
CERS Cerus Corporation Buy 13.22% 7.65%
MCRB Seres Therapeutics, Inc. Buy 12.34% 0.51%
TVTX Travere Therapeutics, Inc. Buy 11.6% 3.16%
ATXS Astria Therapeutics, Inc. Buy 12.41% 10.4%
SNDX Syndax Pharmaceuticals, Inc. Buy 11.71% 4.12%
SAGE Sage Therapeutics, Inc. Buy 11.51% 2.31%
BLUE bluebird bio, Inc. Buy 12.71% 13%
DNLI Denali Therapeutics Inc. Sell -6.15% -6.21%
AGEN Agenus Inc. Sell -5.87% -5.92%
MODV ModivCare Inc. Sell -5.07% 0.28%
NUTX Nutex Health Inc. Sell -7.57% -9.91%
The percentage of cash held in the portfolio is: 13.32%
New Assets Added
None
Assets Removed
Asset Action Perf %
LXRX Buy All -16.25%
Assets Rebalanced
None
2024-07-10 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 11.65% -4.65%
AVXL Anavex Life Sciences Corp. Buy 12.84% 0.67%
CERS Cerus Corporation Buy 12.88% 1.02%
MCRB Seres Therapeutics, Inc. Buy 13.37% 4.83%
TVTX Travere Therapeutics, Inc. Buy 11.68% 0%
ATXS Astria Therapeutics, Inc. Buy 11.68% 0%
SNDX Syndax Pharmaceuticals, Inc. Buy 11.68% 0%
SAGE Sage Therapeutics, Inc. Buy 11.68% 0%
BLUE bluebird bio, Inc. Buy 11.68% 0%
DNLI Denali Therapeutics Inc. Sell -5.8% 3.59%
LXRX Lexicon Pharmaceuticals, Inc. Sell -6.02% 0%
AGEN Agenus Inc. Sell -6.17% -7.23%
MODV ModivCare Inc. Sell -4.85% 8.17%
NUTX Nutex Health Inc. Sell -7.15% 0%
The percentage of cash held in the portfolio is: 20.84%
New Assets Added
  • TVTX
  • ATXS
  • SNDX
  • SAGE
  • BLUE
  • NUTX
Assets Removed
None
Assets Rebalanced
None
2024-07-09 00:00:00 : Portfolio change date
Asset Action Weight PnL
NKTR Nektar Therapeutics Buy 11.89% -3.88%
AVXL Anavex Life Sciences Corp. Buy 12.9% 0%
CERS Cerus Corporation Buy 12.9% 0%
MCRB Seres Therapeutics, Inc. Buy 12.9% 0%
DNLI Denali Therapeutics Inc. Sell -5.93% 2.53%
LXRX Lexicon Pharmaceuticals, Inc. Sell -6.09% 0%
AGEN Agenus Inc. Sell -6.24% -7.09%
MODV ModivCare Inc. Sell -5.27% 1.49%
The percentage of cash held in the portfolio is: 72.93%
New Assets Added
  • AVXL
  • CERS
  • MCRB
Assets Removed
Asset Action Perf %
INGN Buy All -14.99%
Assets Rebalanced
None

Load more previous compositions

Compositions In The Last 2W Compositions In The Last 1M Compositions In The Last 3M Compositions In The Last 6M

Market Overview

Disclaimer Quantam Research does not provide personal investment or financial advice to individuals, or act as personal financial, legal, or institutional investment advisors, or individually advocate the purchase or sale of any security or investment or the use of any particular financial strategy. All investing, assets forecasts and investment strategies include the risk of loss for some or even all of your capital. Before pursuing any financial strategies discussed on this website, you should always consult with a licensed financial advisor.
Cookies Settings